Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Nguyen, V V
Title
A human kidney and liver organoid-based multi-organ-on-a-chip model to study the therapeutic effects and biodistribution of mesenchymal stromal cell-derived extracellular vesicles.
Citation
Journal of extracellular vesicles; 2022 Nov; 11(11) pge12280
PubMed ID
36382606
Show Usages
Product Cited
Cross-Reactivity
Applications
AF-100-15
Human
in vitro
100-26
Human
in vitro
120-10C
Human
in vitro
100-39
Human
in vitro
120-03P
Human
in vitro
100-32
Human
in vitro
First Author
Li, P
Title
Recapitulating hepatitis E virus-host interactions and facilitating antiviral drug discovery in human liver-derived organoids.
Citation
Science advances; 2022 Jan 21; 8(3) pgeabj5908
PubMed ID
35044825
Show Usages
Product Cited
Cross-Reactivity
Applications
AF-100-15
Human
in vitro
100-26
Human
in vitro
100-39H
Human
in vitro
120-03P
Human
in vitro
100-32
Human
in vitro
First Author
Clark, M P
Title
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models
Citation
Cell death & disease; 2021 Jun 23; 12(7) pg641
PubMed ID
34162831
Show Usages
Product Cited
Cross-Reactivity
Applications
AF-100-15
Human
in vitro
100-26
Human
in vitro
100-39H
Human
in vitro
120-10C
Human
in vitro
120-03P
Human
in vitro
100-32
Human
in vitro
First Author
Kanzaki, H
Title
The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma.
Citation
Scientific reports; 2021 Mar 5; 11(1) pg5303
PubMed ID
33674622
Show Usages
Product Cited
Cross-Reactivity
Applications
100-32
Human
in vitro
First Author
Wei, J
Title
Gene manipulation in liver ductal organoids by optimized recombinant adeno-associated virus vectors.
Citation
Journal of Biochemistry;2019 9 20; 294(38) pg14096-14104
PubMed ID
31366731
Show Usages
Product Cited
Cross-Reactivity
Applications
100-39
Human
in vitro
100-32
Human
in vitro
100-26
Mouse
in vitro
First Author
Xiao, Z
Title
A computationally identified compound antagonizes excess FGF-23 signaling in renal tubules and a mouse model of hypophosphatemia.
Citation
Science Signaling; 2016 Nov 22; 9(455) pgra113
PubMed ID
27879395
Show Usages
Product Cited
Cross-Reactivity
Applications
100-17A
Human
in vitro
100-31
Human
in vitro
100-34
Human
in vitro
100-23
Human
in vitro
100-28
Human
in vitro
100-32
Human
in vitro
100-41
Human
in vitro
First Author
Xu, Y
Title
Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
Citation
Biochemical and Biophysical Research Communications; 2014 Mar 28; 446(1) pg54-60
PubMed ID
24565842
Show Usages
Product Cited
Cross-Reactivity
Applications
100-32
Human
in vitro
First Author
Tamimi, Y
Title
FGF19 is a target for FOXC1 regulation in ciliary body-derived cells.
Citation
Human Molecular Genetics; 2006 Nov 1; 15(21) pg3229-40
PubMed ID
17000708
Show Usages
Product Cited
Cross-Reactivity
Applications
100-32
Human
in vitro
showing 8 of 8